Published in Oncol Rep on June 01, 2006
Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer (2010) 3.95
A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma. PLoS One (2014) 1.26
Integrative analysis of many weighted co-expression networks using tensor computation. PLoS Comput Biol (2011) 1.12
Meta-analysis of several gene lists for distinct types of cancer: a simple way to reveal common prognostic markers. BMC Bioinformatics (2007) 1.04
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. Br J Cancer (2008) 0.84
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells. Breast Cancer Res (2012) 0.82
RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells. Braz J Med Biol Res (2012) 0.82
PTTG1 attenuates drug-induced cellular senescence. PLoS One (2011) 0.82
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma. J Hematol Oncol (2015) 0.79
Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/-) transgenic mice. BMC Cancer (2012) 0.79
Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth. PLoS One (2013) 0.79
Securin promotes migration and invasion via matrix metalloproteinases in glioma cells. Oncol Lett (2015) 0.78
Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells. PLoS One (2012) 0.77
Securin promotes the identification of favourable outcome in invasive breast cancer. Br J Cancer (2009) 0.76
Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Oncol Lett (2015) 0.76
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Oncotarget (2016) 0.75
Expression of pituitary tumor-transforming 2 in human glioblastoma cell lines and its role in glioblastoma tumorigenesis. Exp Ther Med (2016) 0.75
Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin. Oncotarget (2017) 0.75
Evaluation of the stability of aneurysms after embolization using detachable coils: correlation between stability of aneurysms and embolized volume of aneurysms. AJNR Am J Neuroradiol (2002) 1.96
Dynamic imaging of somatosensory cortical activity in the rat visualized by flavoprotein autofluorescence. J Physiol (2003) 1.93
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res (2005) 1.76
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma. Clin Cancer Res (2005) 1.65
Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery (2005) 1.43
Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir (Tokyo) (2003) 1.21
EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Mol Cancer Ther (2008) 1.21
Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep (2006) 1.19
Epileptic spikes: magnetoencephalography versus simultaneous electrocorticography. Epilepsia (2002) 1.14
Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus. J Neurosurg (2003) 1.11
Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. J Neurosurg (2005) 1.05
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biol Ther (2010) 1.04
Mild heat shock induces autophagic growth arrest, but not apoptosis in U251-MG and U87-MG human malignant glioma cells. J Neurooncol (2004) 0.98
Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg (2007) 0.95
Hemifacial spasm associated with an ependymal cyst in the cerebellopontine angle. Case report. J Neurosurg (2002) 0.95
Gene expression signature-based prognostic risk score in patients with glioblastoma. Cancer Sci (2013) 0.93
Dendritic cell-based glioma immunotherapy (review). Int J Oncol (2003) 0.92
M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. J Clin Exp Hematop (2011) 0.92
Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol (2004) 0.91
Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12. J Neurosurg (2002) 0.89
Proliferative effects of angiotensin II and endothelin-1 on guinea pig gingival fibroblast cells in culture. Comp Biochem Physiol C Toxicol Pharmacol (2002) 0.88
Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients. Cancer Sci (2013) 0.87
Etiopathological factors related to hydrocephalus associated with vestibular schwannoma. Neurosurgery (2007) 0.87
A primary CNS lymphoma in spontaneous remission for 3.5 years after initial detection of the lesions by MRI. Brain Tumor Pathol (2003) 0.86
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma. Cancer Immunol Immunother (2003) 0.86
Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol Rep (2006) 0.86
Lateral spread response elicited by double stimulation in patients with hemifacial spasm. Muscle Nerve (2002) 0.86
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma. Clin Cancer Res (2012) 0.84
Endoscopic stent placement for treatment of secondary bilateral occlusion of the Monro foramina following endoscopic third ventriculostomy in a patient with aqueductal stenosis. Case report. J Neurosurg (2007) 0.83
Frontal anaplastic oligodendroglioma showing multi-organ metastases after a long clinical course. Case report. Neurol Med Chir (Tokyo) (2007) 0.83
Giant cell reparative granuloma of the temporal bone: neuroradiological and immunohistochemical findings. Neurol Med Chir (Tokyo) (2002) 0.83
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients. Cancer Sci (2008) 0.82
Short-term plasticity visualized with flavoprotein autofluorescence in the somatosensory cortex of anaesthetized rats. Eur J Neurosci (2004) 0.82
Proteomic characterization of primary diffuse large B-cell lymphomas in the central nervous system. J Neurosurg (2008) 0.82
Pharmacological properties of angiotensin II receptors in cultured rabbit gingival fibroblasts. Comp Biochem Physiol C Toxicol Pharmacol (2004) 0.82
Ictal SPECT in supplementary motor area seizures. Neurol Res (2006) 0.82
Modified buddy wire technique for coil embolization of posterior circulation aneurysms. Neuroradiology (2006) 0.82
Tentorial cavernous angioma with profuse bleeding. Case report. J Neurosurg Pediatr (2009) 0.81
Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients. Int J Oncol (2011) 0.81
Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA. J Neurosurg (2002) 0.81
Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients. Oncol Rep (2007) 0.81
Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol (2001) 0.81
Fusiform gyrus epilepsy: the use of ictal magnetoencephalography. Case report. J Neurosurg (2002) 0.81
Results of treatment of 112 cases of primary CNS lymphoma. Jpn J Clin Oncol (2008) 0.81
Ictal SPECT analyzed by three-dimensional stereotactic surface projection in frontal lobe epilepsy patients. Epilepsy Res (2005) 0.81
Endoscopic biopsies of lesions associated with a thickened pituitary stalk. Acta Neurochir (Wien) (2012) 0.81
Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature. J Neurooncol (2014) 0.81
Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. J Neurooncol (2005) 0.80
[Abnormal muscle response monitoring during microvascular decompression for hemifacial spasm and long term results]. No Shinkei Geka (2006) 0.80
Monitoring of the lateral spread response in the endovascular treatment of a hemifacial spasm caused by an unruptured vertebral artery aneurysm. Case report. J Neurosurg (2004) 0.80
False lateralization of mesial temporal lobe epilepsy by noninvasive neurophysiological examinations. Neurol Med Chir (Tokyo) (2006) 0.80
Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients. Oncol Rep (2008) 0.79
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen. Leuk Lymphoma (2007) 0.79
Ischemic depolarization monitoring: evaluation of protein synthesis in the hippocampal CA1 after brief unilateral ischemia in a gerbil model. J Neurosurg (2002) 0.79
Successful removal of a huge hypervascular tentorial cavernous angioma after preoperative endovascular embolization. J Neurosurg Pediatr (2014) 0.79
Multiple large cerebral cavernous angioma in childhood. Pediatr Neurosurg (2003) 0.78
Extracerebral ectopic mass with huge cysts in the anterior cranial cavity. Neuropathology (2003) 0.78
Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report. Leuk Lymphoma (2007) 0.77
[Complications and diagnostic yield of stereotactic biopsy for the patients with malignant brain tumors]. No Shinkei Geka (2004) 0.77
[Presurgical functional mapping of the sensorimotor area using evoked magnetic fields]. No Shinkei Geka (2002) 0.77
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma. Ann Hematol (2005) 0.77
Immunohistochemical analysis of myelination following hemicranial irradiation in neonatal rats. Neurosci Lett (2003) 0.77
Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma. Oncol Rep (2008) 0.77
Serial evaluation of axonal function in patients with brain death by using anisotropic diffusion-weighted magnetic resonance imaging. J Neurosurg (2004) 0.77
Interstitial hyperthermia with intra-arterial injection of adriamycin for malignant glioma. Neurol Med Chir (Tokyo) (2006) 0.77
Transcranial imaging of audiogenic epileptic foci in the cortex of DBA/2J mice. Neuroreport (2006) 0.77
A fourth ventricle atypical teratoid/rhabdoid tumor in an infant. Brain Tumor Pathol (2003) 0.76
Isolation and characterization of an N-linked oligosaccharide that is increased in glioblastoma tissue and cell lines. Int J Oncol (2005) 0.76
Gene therapy of brain tumor with endostatin. Drugs Today (Barc) (2004) 0.76
Taxation categories for long-term care insurance premiums and mortality among elderly Japanese: a cohort study. J Epidemiol (2012) 0.75
CCAAT/enhancer binding proteins are expressed in the gerbil hippocampus after transient forebrain ischemia. Neurosci Lett (2003) 0.75
Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells. Int J Hyperthermia (2005) 0.75
Basal ganglion hamartoma in a patient presenting with precocious puberty. Brain Tumor Pathol (2005) 0.75
Current status of neuroendoscopic surgery in Japan and discussion on the training system. Childs Nerv Syst (2007) 0.75
Long-term survivors of primary central nervous system lymphoma. Jpn J Clin Oncol (2017) 0.75